Keywords: daiichi, sankyo, eli, lilly, submit, nda, fda

Daiichi Sankyo and Eli Lilly submit NDA to US FDA for prasugrel; to be sold as Effient

Article | 14 January 2008

Print This

Japanese drugmaker Daiichi Sankyo and US drug major Eli Lilly have submitted a New Drug Application for prasugrel to the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in